Abstract
Three patients with subacute ischemic cerebral infarction examined by SPECT with99mTc-ECD and PET within the same day showed signs of luxury perfusion in the subacute phase, which is between 9 to 20 days after the onset. A99mTc-HMPAO SPECT study was also performed within 2 days of the ECD-SPECT study.
ECD-SPECT images of three patients displayed a focal decreased uptake in the infarcted lesions, while in infarcted foci, there was almost equivalent or increased CBF compared to normal and unaffected areas, decreased CMRO2, and high HMPAO uptake. The ECD-SPECT results were similar to those of CMRO2 rather than CBF, though the HMPAO-SPECT image was similar to that of CBF. In one patient, HMPAO images revealed hyperfixation of the tracer. In the chronic phase and in the acute phase before 5 days after the onset, there were no discrepancies among the ECD-SPECT, CBF, HMPAO-SPECT, and CMRO2 images.
These observations indicated that99mTc-ECD is a good indicator of damaged brain tissues in subacute ischemic infarction. They also suggested that99mTc-ECD is a potential agent with which to evaluate cerebral tissue viability in some pathological states of cerebrovascular disease. The characteristics may be suitable for confirming the effects of thrombolytic therapy in acute ischemia, because these conditions often show signs of luxury perfusion when the therapy is successful.
References
Cheesman EH, Blanchette MA, Ganey MV, Maheu LJ, Miller SJ, Watson AD. Technetium-99m ECD: Esterderivatized diaminedithiol Tc complexes for imaging brain perfusion.J Nucl Med 29: 788, 1988.
Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Leveille J, Gherardi PG, et al. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction.J Nucl Med 30: 1018–1024, 1989.
Leveille J, Botez MI, Taillefer R, Gagnon A, Douesnard JM, Lefebvre B. A clinical comparison of Tc-99m HMPAO and Tc-99m ethyl cysteinate dimer (ECD) in normal volunteers and patients as a brain perfusion imaging agent.J Nucl Med 29: 844, 1988.
Moretti JL, Defer G, Cinotti L, Cesaro P, Vigneron N, Pethe C. Comparative tomographic study of strokes using Tc-99m ECD, Tc-99m HMPAO and I-123 IMP. Preliminary results.Eur J Nucl Med 14: 311, 1988.
Demonceau G, Leveille J, Moretti JL, De Roo M, Rigo P, Walovitch RC. Chronic stroke: Comparison of ECD, HM-PAO, and CT-scan.Eur JNucl Med 15: 458, 1989.
Devous MD, Leroy RF, Payne JK, Lorimer MK, Bonte FJ. Comparison of Tc-99m ECD to Xe-133 in the SPECT determination of regional cerebral blood flow in patients with mild perfusion abnormalities.J Nucl Med 31: 817, 1990.
Shishido F, Uemura K, Murakami M, Inugami A, Ogawa T, Fujita H, et al. Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET.KAKU IGAKU (Jpn J Nucl Med) 29: 27–35, 1992.
Shishido F, Uemura K, Murakami M, Inugami A, Ogawa T, Fujita H, et al. Cerebral uptake of99mTc-Bicisate in patients with cerebrovascular disease in comparison with CBF and CMRO2 measured by positron emission tomography.J Cereb Blood Flow Metab 14(Suppl. 1): S66-S75, 1994.
Lassen NA, Sperling B.99mTc-Bicisate reliably images CBF in chronic brain diseases but fails to show reflow hyperemia in subacute stroke: Report of a multicenter trial of 105 cases comparing133Xeand99mTc-Bicisate(ECD, Neurolite) measured by SPECT on the same day.J Cereb Blood Flow Metab 14(Suppl. 1): S44-S48, 1994.
Nakagawara J, Nakamura J, Takeda R, Okumura T, Seki T, Hayase K, et al. Assessment of postischemic reperfusion and Diamox activation test in stroke using99mTc-ECD SPECT.J Cereb Blood Flow Metab 14 (Suppl. 1): S49-S57, 1994.
Walovitch RC, Cheesman EH, Maheu LJ, Hall KM. Studies of the retention mechanism of the brain perfusion imaging agent99mTc-bicisate (99mTc-ECD).J Cereb Blood Flow Metab 14 (Suppl. 1): S4-S11, 1994.
Sperling B, Lassen NA. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT.Stroke 24: 193–194, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shishido, F., Uemura, K., Inugami, A. et al. Discrepant99mTc-ECD images of CBF in patients with subacute cerebral infarction: A comparison of CBF, CMRO2 and99mTc-HMPAO imaging. Ann Nucl Med 9, 161–166 (1995). https://doi.org/10.1007/BF03165046
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03165046